LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Large Joints and Extremities/Major Milestone – 25,000 TKRs/5,000 BalanceBots – for Corin
Large Joints and Extremities

Major Milestone – 25,000 TKRs/5,000 BalanceBots – for Corin

March 20, 2020 2 min read Premium comments

Advertisement

Major Milestone – 25,000 TKRs/5,000 BalanceBots – for Corin
OMNIBotics BalanceBot / Courtesy of Corin
#totalkneereplacementSecondary#corin#balancebot#omnibotics

London, UK-based Corin has announced that its OMNIBotics robotic-assisted platform has recently completed 25,000 total knee arthroplasties (TKA), including 5,000 procedures using the company’s BalanceBot ligament balancing robotic device.

The BalanceBot receives feedback from soft tissue and ligaments through the whole range of joint motion, thus aiding accurate knee joint balancing.

According to the Corin, The BalanceBot, when used in the Predictive Balance technique, accurately predicts the effect that implant positioning will have on knee gaps in flexion, extension and mid-flexion. Because of this more precise ligament balancing, surgeons can target knee gaps that correlate with better outcomes and less pain. The platform can also be used intra-operatively to assess the patient’s overall knee stability throughout the full range of motion with the joint in situ.”

Jeffrey H. DeClaire, M.D. of the DeClaire LaMacchia Orthopedic Institute, in Rochester, Michigan, is one of the first orthopedic surgeons to use BalanceBot. In his opinion, “OMNIBotics, and the use of the BalanceBot device, is a significant improvement to the field of knee replacement. The ability to plan implant position to best balance the knee’s soft tissues using the Predictive Balance software, on top of the consistency and reproducibility that comes with robotics, is remarkable. The immediate results are noticeable and I’m excited to continue monitoring my patients and track their recoveries.”

Chris Plaskos, Ph.D., Corin’s VP of Global Clinical Innovation said: “The experience gained from over 5,000 surgeries with the BalanceBot has been invaluable to understanding soft tissue balancing and its effects on patient outcomes and future advancements. As a company, we are proud to have reached this major milestone and we continue to provide our customers with innovative technologies which are revolutionizing joint replacement for patients and surgeons.”

Furthermore, said Plaskos to OTW, “We know that patients undergoing knee surgery are sometimes not as satisfied with the results of their surgery, in comparison to those patients receiving hip surgery. Corin’s innovation team saw this opportunity to not only improve patient outcomes but also surgical technique. There is still room for improvement within total knee arthroplasty, but the OMNIBotics and BalanceBot technologies mark a notable step forward.”

“The OMNIBotics BalanceBot platform provides surgeons with the ability to address and balance the soft tissues surrounding the knee in a predictable and reproducible manner. The system demonstrates how robotics can be used to simplify the surgical process, and to help plan for challenging cases and adapt procedures while in the OR as necessary.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy